Urology & Nephrology Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

IO toxicities in Kidney Cancer
Jean-Marie Michot, MD Drug Development Department Gustave Roussy, France jean-marie.michot@gustaveroussy.fr discusses IO toxicities in Kidney Cancer at the Kidney Cancer Association International Sym... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Update in IO Neoadjuvant (Preoperative) Trials
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology discusses Update in IO Neoadjuvant (Preoperative) Trialsat the Kidney Cancer Association Inte... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

New targets in rcc:nktr
Cristina Surez MD PhD Hospital Universitari Vall dHebron-Vall dHebron Institute of Oncology discusses NEW TARGETS IN RCC:NKTR at the Kidney Cancer Association International Symposium 2019 in Dubro... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Targeting RCC Metabolism: Glutaminase Inhibition
Brian Shuch, MD Associate Professor of Urology Director, UCLA Kidney Cancer Program Alvin & CarrieMeinhardt Endowed Chair in Kidney Cancer Research discusses Targeting RCC Metabolism: Glutaminase I... Author: superboy Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts

TIL products from Renal Cell Carcinomas are tumor-specific but poor cytokine producers
Monika Wolkers, PhD m.wolkers@sanquin.nl discusses TIL products from Renal Cell Carcinomas are tumor-specific but poor cytokine producers at the Kidney Cancer Association International Symposium 2019 ... Author: superboy Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts

New targets in rcc
Bernadett Szabados of Barts Cancer Institute discusses NEW TARGETS IN RCC at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia Author: superboy Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts

Novel epigenetic targeting approaches
W. Kimryn Rathmell, MD, PhD of Vanderbilt Ingram Cancer Center discusses Novel epigenetic targeting approaches at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia Author: superboy Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts

HIF-2aa new target in metastatic RCC
Laurence Albiges, Gustave Roussy Villejuif, France discusses HIF-2aa new target in metastatic RCCat the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia Author: superboy Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts

Learning curves in 500 robot-assisted partial nephrectomies: the bed-side assistant counts
Philip Zeuschner, MD of Universitt des Saarlandes, Saarbrcken (UKS) discusses Learning curves in 500 robot-assisted partial nephrectomies: the bed-side assistant counts at the Kidney Cancer Associat... Author: kidneycancer Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts

A First-in-Human Phase 1/2 Trial of the Oral HIF-2a Inhibitor PT2977 in Patients with Advanced RCC
Toni K. Choueiri, MD of Dana-Farber Cancer Institute, Boston, MA discusses A First-in-Human Phase 1/2 Trial of the Oral HIF-2a Inhibitor PT2977 in Patients with Advanced RCCat the Kidney Cancer Assoc... Author: kidneycancer Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts

Small renal masses non surgical management
Prof. Alessandro VOLPE University of Eastern Piedmont Maggiore della Carit Hospital, Novara, Italy discusses SMALL RENAL MASSES NON SURGICAL MANAGEMENT at the Kidney Cancer Association International ... Author: kidneycancer Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts

Optimising advanced RCC treatment: the place of Fotivda(tivozanib) in 2019 and beyond
Manuela Schmidinger, MD, Camillo Porta, MD, Romano Danesi, MD, PhD, Brian I. Rini, MD discuss Optimising advanced RCC treatment: the place of Fotivda(tivozanib) in 2019 and beyond at the Kidney Ca... Author: kidneycancer Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts

Oligometastatic disease: Localized vs systemic therapy Non-surgical local management of RCC
Dr Emmanuel MEYER Department of radiation oncology Centre Franois Baclesse Caen - France discusses Oligometastatic disease: Localized vs systemic therapy Non-surgical local management of RCC at t... Author: kidneycancer Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts

Ablative Therapies Versus Surgery: How the Evidence May Be Improved?
Fernando Gmez Muoz. MD PhD Vascular and Interventional Radiology Hospital Clinic de Barcelona Hospital Sant Joan de Deu, Barcelona Netherlands Kanker Instituut, Amsterdam dicusses Ablative Thera... Author: kidneycancer Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts

Stereotactic Ablative Body RadioTherapy in Kidney Cancer
Stereotactic Ablative Body RadioTherapy in Kidney Cancer Ben Vanneste, MD, PhD Radiation-Oncologist, MAASTRO Clinic, The Netherlands discusses Stereotactic Ablative Body RadioTherapy in Kidney Can... Author: kidneycancer Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts